U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX24360690: GSM8229593: cript_c_output_biolrep3; Saccharomyces cerevisiae; OTHER
1 ILLUMINA (NextSeq 500) run: 15.3M spots, 4.6G bases, 1.8Gb downloads

External Id: GSM8229593_r1
Submitted by: Ben Lehner, Centre for Genomic Regulation
Study: A complete map of affinity and specificity encoding for a partially fuzzy protein interaction
show Abstracthide Abstract
Thousands of protein domains encoded in the human genome function by binding up to a million short linear motifs embedded in intrinsically disordered regions of other proteins. How affinity and specificity are encoded in these binding domains and the motifs themselves is not well understood. The evolvability of binding specificity - how rapidly and extensively it can change upon mutation - is also largely unexplored, as is the contribution of 'fuzzy' dynamic residues to affinity and specificity in protein-protein interactions. Here we produce the first global map of affinity and specificity encoding in a globular protein domain. Quantifying >200,000 energetic interactions between the domain and ligand allows us to identify 20 major energetically coupled pairs of sites. These are organised into six modules, with the vast majority of mutations in each module only reprogramming specificity for a single position in the ligand. Nine of the major energetic couplings encoding specificity are direct structural contacts and 11 have an allosteric mechanism of action. The dynamic tail of the ligand is more robust to mutation than the structured portion but contributes additively to binding affinity and communicates with structured residues to enable changes in specificity. Our results present how affinity and specificity are encoded in a globular protein domain interacting with a disordered peptide and a direct comparison of the encoding of affinity and specificity in structured and dynamic molecular recognition. Overall design: Input and output samples of DNA amplicons from libraries of variants used to quantify fitness/protein binding scores of different variants of PSD95-PDZ3 and CRIPT proteins. Libraries were transformed into yeast and subjected to a protein complementation assay with or without a selective drug.
Sample: cript_c_output_biolrep3
SAMN41074547 • SRS21118154 • All experiments • All runs
Library:
Name: GSM8229593
Instrument: NextSeq 500
Strategy: OTHER
Source: GENOMIC
Selection: other
Layout: PAIRED
Construction protocol: Cell pellets (one for each experiment input/output replicate) were re-suspended in 1 mL of DNA extraction buffer (2% Triton-X, 1% SDS, 100mM NaCl, 10mM Tris-HCl pH8, 1mM EDTA pH8), frozen by dry ice-ethanol bath and incubated at 62ºC water bath twice. Subsequently, 1 mL of Phenol/Chloro/Isoamyl 25:24:1 (equilibrated in 10mM Tris-HCl, 1mM EDTA, pH8) was added, together with 1 g of acid-washed glass beads (Sigma Aldrich) and the samples were vortexed for 10 minutes. Samples were centrifuged at RT for 30 minutes at 4,000 rpm and the aqueous phase was transferred into new tubes. The same step was repeated twice. 0.1 mL of NaOAc 3M and 2.2 mL of pre-chilled absolute ethanol were added to the aqueous phase. The samples were gently mixed and incubated at -20ºC for 30 minutes. They were then centrifuged for 30 min at full speed at 4ºC to precipitate the DNA. The ethanol was removed and the DNA pellet was allowed to dry overnight at RT. DNA pellets were resuspended in 0.6 mL TE 1X and treated with 5 uL of RNaseA (10mg/mL, Thermo Scientific) for 30 minutes at 37ºC. To desalt and concentrate the DNA solutions, QIAEX II Gel Extraction Kit was used (30 μL of QIAEX II beads). The samples were washed twice with PE buffer and eluted twice by 125 μL of 10 mM Tris-HCI buffer, pH 8.5 and then combined two elution. Finally, plasmid concentrations in the total DNA extract (that also contained yeast genomic DNA) were quantified by qPCR using the primer pair oGJJ152-oGJJ153, that binds to the ori region of the plasmids. We performed 2 consecutive PCR reactions for each sample (PCR1 and PCR2). In PCR1, we added frameshifting oligonucleotides and amplified the regions of interest (amplicon with constant region and mutated region) from the extracted DNA with 5 cycles. In PCR2 we added Illumina sequencing barcodes with PCR using the minimum number of cycles necessary to reach amplification plateau for each sample based on a qPCR run. The amplicon library pools were run on a 2% agarose gel and were purified using QIAEX II Gel Extraction Kit (QIAGEN) and using 30uL of QIAEX II beads for each sample. The purified amplicons were subjected to Illumina 150bp paired-end NextSeq sequencing. PCR amplicon
Runs: 1 run, 15.3M spots, 4.6G bases, 1.8Gb
Run# of Spots# of BasesSizePublished
SRR2879647715,293,3554.6G1.8Gb2024-04-25

ID:
32675346

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...